NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/16/2025
Back to search
Official data from USPTO
CSL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
07/08/2025
Trademark type
Word
Nice classes
1, 5
Filing date
09/15/2016
Registration date
07/24/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2025
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Parkville, Victoria, AU
Examiner
NEHMER, JASON
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CSL Limited
Representatives
Scott D. Woldow Smith, Gambrell & Russell, LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screeningblood groupingfor the typing and detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant compliment components and immunoglobulin subtypes; cell cultures and mediabiological preparations for use in cell cultures other than for medical and veterinary use; cell growth media for growing cells for use in scientific research; cell media for growing cells for use in scientific researchfor use in the production of pharmaceuticalsvaccinesmonoclonal antibodies and recombinant proteins; chemical test kits for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant compliment compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific purposes and for use in industry; chemical preparationsdiagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology in the nature of reagents for use in the preparation of invitro diagnostic kits; chemical preparationsmonoclonal antibodies for use in invitro scientific or research use; chemical preparations for industrial use for anti-body screeningblood groupingthe typing and detection of specific blood cells; diagnostic and testing agents for scientific or research usereagents for use in anti-body screeningblood grouping and the typing and detecting of specific blood cells; diagnostic reagents and preparations except for medical or veterinary use
Class 5
Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disordersinfluenzarespiratory disease and disorders; pharmaceutical preparations and substances for the treatment and/or prevention of stroke or heart failure; vaccines; anti-virals; antigens for medical purposes; blood products in this classblood plasmareagent blood cells; products derived from blood and products derived from recombinant DNA technologyimmunoglobulinshuman albuminblood clotting factorsplasma volume expandersblood proteins for therapeutic use; serumsanti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the classinvitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substancesRhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparationsreagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparationsmonoclonal and polyclonal antibodies; pharmaceutical preparationsreagents for medical/clinical use for the typing and detection of specific blood cellsthe detection of relevant compliment components and immunoglobulin subtypes
Publications
History of USPTO decisions and trademark events.
38 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
06/16/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/13/2025
ES8R
TEAS SECTION 8 RECEIVED
07/19/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/24/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/24/2018
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/15/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/15/2018
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/18/2018
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/18/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/21/2017
EX1G
SOU EXTENSION 1 GRANTED
11/17/2017
EXT1
SOU EXTENSION 1 FILED
11/17/2017
EEXT
SOU TEAS EXTENSION RECEIVED
11/17/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/23/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2017
PUBO
PUBLISHED FOR OPPOSITION
03/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/22/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2017
ALIE
ASSIGNED TO LIE
02/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/17/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/27/2016
GNRT
NON-FINAL ACTION E-MAILED
12/27/2016
CNRT
NON-FINAL ACTION WRITTEN
12/27/2016
DOCK
ASSIGNED TO EXAMINER
12/21/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/20/2016
NWAP
NEW APPLICATION ENTERED
09/19/2016
Continuous trademark protection
Get notified about every new filing that threatens CSL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.